GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Think Research Corp (TSXV:THNK) » Definitions » Debt-to-EBITDA

Think Research (TSXV:THNK) Debt-to-EBITDA : -141.38 (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Think Research Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Think Research's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$29.26 Mil. Think Research's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$21.64 Mil. Think Research's annualized EBITDA for the quarter that ended in Sep. 2023 was C$-0.36 Mil. Think Research's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 was -141.38.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Think Research's Debt-to-EBITDA or its related term are showing as below:

TSXV:THNK' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -4.88   Med: -1.92   Max: 87.15
Current: 87.15

During the past 3 years, the highest Debt-to-EBITDA Ratio of Think Research was 87.15. The lowest was -4.88. And the median was -1.92.

TSXV:THNK's Debt-to-EBITDA is ranked worse than
100% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 2.58 vs TSXV:THNK: 87.15

Think Research Debt-to-EBITDA Historical Data

The historical data trend for Think Research's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Think Research Debt-to-EBITDA Chart

Think Research Annual Data
Trend Sep20 Dec21 Dec22
Debt-to-EBITDA
-1.71 -1.92 -4.88

Think Research Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.56 -15.36 57.33 9.85 -141.38

Competitive Comparison of Think Research's Debt-to-EBITDA

For the Health Information Services subindustry, Think Research's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Think Research's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Think Research's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Think Research's Debt-to-EBITDA falls into.



Think Research Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Think Research's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(26.848 + 19.652) / -9.524
=-4.88

Think Research's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(29.256 + 21.639) / -0.36
=-141.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2023) EBITDA data.


Think Research  (TSXV:THNK) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Think Research Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Think Research's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Think Research (TSXV:THNK) Business Description

Traded in Other Exchanges
Address
199 Bay Street, Suite 4000, Toronto, ON, CAN, M5L 1A9
Think Research Corp and its subsidiaries are a healthcare technology company digitalizing the delivery of knowledge to facilitate better healthcare outcomes. The company gathers, develops, and delivers a knowledge-based Software-as-a-Service solution globally to customers which typically includes enterprise clients, hospitals, health regions, healthcare professionals, and/or governments. Its cloud-based, EMR-agnostic digital tools have empowered clinicians around the world and positively impacted millions of patients across the continuum of care, including primary physician care, acute care hospitals and surgical suites as well as community and senior care.
Executives
Christopher Collenette Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Patrick Craib Senior Officer
John Hayes Senior Officer
Anna Taylor Senior Officer

Think Research (TSXV:THNK) Headlines

No Headlines